Dmp53 Activates the Hippo Pathway to Promote Cell Death in Response to DNA Damage  by Colombani, Julien et al.
Current Biology 16, 1453–1458, July 25, 2006 ª2006 Elsevier Ltd All rights reserved DOI 10.1016/j.cub.2006.05.059
Report
Dmp53 Activates the Hippo Pathway
to Promote Cell Death
in Response to DNA DamageJulien Colombani,1 Ce´dric Polesello,1 Filipe Josue´,1
and Nicolas Tapon1,*
1Apoptosis and Proliferation Control Laboratory
Cancer Research UK
London Research Institute
44 Lincoln’s Inn Fields
London WC2A 3PX
United Kingdom
Summary
Developmental and environmental signals control
a precise program of growth, proliferation, and cell
death. This program ensures that animals reach, but
do not exceed, their typical size [1]. Understanding
how cells sense the limits of tissue size and respond
accordingly by exiting the cell cycle or undergoing ap-
optosis has important implications for both develop-
mental and cancer biology. The Hippo (Hpo) pathway
comprises the kinases Hpo and Warts/Lats (Wts), the
adaptors Salvador (Sav) and Mob1 as a tumor sup-
pressor (Mats), the cytoskeletal proteins Expanded
and Merlin, and the transcriptional cofactor Yorkie
(Yki) [2–11]. This pathway has been shown to restrict
cell division and promote apoptosis. The caspase
repressor DIAP1 appears to be a primary target of
the Hpo pathway in cell-death control. Firstly, Hpo pro-
motes DIAP1 phosphorylation, likely decreasing its
stability. Secondly, Wts phosphorylates and inacti-
vates Yki, decreasing DIAP1 transcription. Although
we understand some of the events downstream of
the Hpo kinase, its mode of activation remains myste-
rious. Here, we show that Hpo can be activated by Ion-
izing Radiations (IR) in a Dmp53 (Drosophila mela-
nogaster p53)-dependent manner and that Hpo is
required (though not absolutely) for the cell death re-
sponse elicited by IR or Dmp53 ectopic expression.
Results and discussion
Hpo is the ortholog of the Mammalian Sterile Twenty-like
(MST) kinases, which belong to the Ste20 family of ki-
nases. MSTs are highly similar to Hippo (Hpo) in their
N-terminal serine/threonine kinase domains as well as
in the C-terminal Salvador (Sav) binding region (or
SARAH domain) [12–15]. MST1 functions both down-
stream and upstream of caspases to promote chromatin
condensation and nuclear fragmentation, as well as ac-
tivation of the JNK (Jun N-terminal kinase) and p38 path-
ways [16–19]. Like most Ste20 family kinases, MST1/2
auto- or trans-phosphorylates at a number of residues.
One of these, T183 in the activation loop, has been
shown to be required for full kinase activity and has
been used as a useful marker of MST1 activation in
*Correspondence: nicolas.tapon@cancer.org.ukcultured cells [20–22]. In order to study events upstream
of Hpo, we tested antibodies that have previously been
shown to recognize MST1/2 phosphorylated on T183 for
their ability to cross-react with Hpo on the equivalent
residue (T195). Interestingly, we found antibodies that
specifically recognized the phosphorylated form of
Hpo upon treatment with staurosporine (sts), a known
activator of MST1/2 (Figures 1A; also Figure S1A in the
Supplemental Data available with this article online).
This signal was abolished by RNAi-mediated Hpo deple-
tion and disappeared upon phosphatase treatment
(Figure 1A, fourth lane, and Figure 1C). Moreover, the an-
tibodies recognize overexpressed tagged Hpo before
(Figure S1B) or after (Figure S1C) immunoprecipitation.
By contrast, the antibodies did not recognize a nonphos-
phorylable (T195A) Hpo mutant protein (Figure 1B and
data not shown). We immunoprecipitated Myc-tagged
wild-type and T195A Hpo and measured their auto-ki-
nase activity and their activity on an exogenous sub-
strate (Histone H2B, not shown) in both the presence
and absence of sts (Figure 1B). As has been observed
for MST1/2, overexpression of Hpo leads to its activa-
tion, presumably via trans-phosphorylation. Sts treat-
ment potently stimulated Hpo kinase activity (5-fold).
By contrast, the T195A mutant was severely compro-
mised both in its unstimulated and stimulated activities
(15- and 10-fold reductions, respectively), suggesting
that T195 phosphorylation is crucial to normal Hpo ki-
nase activity, as has been shown for the MSTs [20].
Thus, these phospho-specific antibodies can be used
as readouts of Hpo pathway activity.
In the course of testing stimuli that would activate Hpo
in tissue culture, we observed that g-irradiation potently
and rapidly induced Hpo activation (Figure 4A). Dmp53,
the fly p53 ortholog, has been shown to mediate cell
death upon ionizing radiation (IR)-induced DNA damage
[23]. Although the pro-apoptotic genes reaper (rpr), hid,
and sickle are Dmp53 transcriptional targets [24, 25], re-
moval of these three proteins via chromosomal defi-
ciencies only partially suppresses the cell-death effects
of IR in embryos, suggesting that additional death sig-
nals act downstream of Dmp53 [26]. This prompted us
to examine whether the Hpo pathway could function
downstream of Dmp53 in the response to IR.
First, we treated wing imaginal discs (the larval pre-
cursors of the adult wing) containing clones of hpo,
wts, and sav mutant cells with g-rays and examined
cell death by staining for activated caspases (Figure 2).
Interestingly, we noted that, although caspase activa-
tion was efficiently induced in wild-type tissue (Figures
2D–2F, GFP-positive areas) or control discs (Figure 2B),
cell death was severely reduced in hpo,wts, and savmu-
tant clones (Figure 2, GFP-negative areas) and inDmp53
mutant discs (Figure 2C). Quantification of the caspase
staining indicated that apoptosis was reduced by 2- to
3-fold in hpo, wts, and sav clones compared to wild-
type tissue (Figure 2G; also Figure S4). This was also
true in eye imaginal discs (not shown).
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late larval eye imaginal dics was sufficient to induce ap-
optosis (Figures 3A and 3B). Loss of function of hpo,
wts, and sav decreased cell death in this context, al-
though the effect was less pronounced in sav clones,
perhaps as a reflection of the weaker phenotype of the
sav mutants (Figures 3C–3E). This suggests that
the Hpo complex may function as an effector in the
Dmp53-mediated response to IR. To test this hypothe-
sis, we first measured Hpo activation in cultured cells
treated with g-rays in the presence or absence of
dsRNAs directed against Dmp53 (Figure 4A). Excitingly,
depletion of Dmp53 markedly reduced Hpo phosphory-
lation by IR. The residual level of Hpo activation we ob-
served in Dmp53-depleted cells can probably be ex-
plained by the fact that the dsRNA-mediated Dmp53
depletion was never complete, as measured by RT-
PCR (Figure S2A). To check that the increased Hpo
phosphorylation we observed corresponded to in-
creased activity, we performed IP kinase assays on cells
expressing ectopic Hpo (Figure 4B). We observed that
IR treatment potently induced Hpo kinase activity
(Figure 4B, compare lanes 1 and 2). Furthermore,
Dmp53 expression alone, in the absence of IR, was suf-
ficient to activate Hpo phosphorylation (Figure 4D,
Figure 1. Phospho-Specific Antibodies as Readouts for Hpo Path-
way Activity
(A) Antibodies directed against phospho-Mst1 and phospho-PAK1/
2 specifically recognize phospho-Hpo upon activating treatment
with sts (compare lanes 1 and 2). This is abolished by RNAi-medi-
ated Hpo depletion (lanes 3 and 4). Identical results were obtained
with three different hpo dsRNAs (not shown). An asterisk denotes
a nonspecific band as a loading control.
(B) Wild-type and mutant (T195A) Myc-tagged Hpo were precipi-
tated from Kc cell lysates treated as shown. IP kinase assays were
performed in the presence of 32Pg-ATP on nine-tenths of the IPs
(top lane), whereas one-tenth were used to check levels of P-Hpo
and Hpo-Myc (middle and bottom lanes).
(C) Phosphatase treatment abolishes the phospho-Hpo signal.
Transfection of tagged Hpo protein (Hpo-Myc) induces Hpo phos-
phorylation by trans-phosphorylation. The phospho-Hpo signals
disappear upon phosphatase treatment.lane 4). Finally, we determined whether Dmp53-depen-
dent Hpo activation could be observed in vivo by taking
advantage of the fact that Dmp53 is not required for vi-
ability. We treated dissected ovaries from Dmp53 mu-
tant and wild-type flies with g-rays and examined Hpo
activity by Western blotting (Figure 4C). Interestingly, al-
though g-rays potently activated Hpo in wild-type flies,
this response was abolished in Dmp53 mutant animals.
Dmp53 expression in the ovaries was able to induce ap-
optosis, ovary degeneration, and total loss of fecundity
(Figure S2, compare panels G and H). We conclude that
Hpo is activated as part of a Dmp53-dependent DNA-
damage response both in cultured cells and in vivo
(Figure 4).
MST1 and 2 are known to be activated by caspase 3
through proteolytic cleavage [16, 17]. Therefore, the
possibility existed that the Hpo activation we observed
was merely a by-product of Rpr-dependent caspase ac-
tivation. Several lines of evidence suggest that this is not
the case. First, reaper overexpression in S2 cells did not
increase Hpo activity (Figure 4D, sixth lane). Second, de-
pletion of DIAP1 from cultured cells, which potently in-
duces caspase activation, fails to trigger detectable
Hpo activation (Figure 4E; also Figures S2B–S2E). Third,
the phospho-Hpo signal we detected corresponds to
full-length Hpo rather than a caspase-cleaved fragment.
In fact, the caspase cleavage site present in the MSTs is
not thought to be conserved in Hpo, and we have seen
no evidence of Hpo cleavage upon apoptotic stimuli.
Fourth, treatment of cultured cells with caspase inhibi-
tors did not affect Hpo activation by IR (data not shown).
Thus, it is unlikely that Hpo is stimulated via Dmp53-
dependent caspase activation.
The time course of Hpo activation by IR (2–3 hr for
maximal activation) suggests that transcription may be
required for this response. Indeed, treatment of cells
with IR in the presence of the transcription inhibitor Ac-
tinomycin D (ActD) abolished Hpo activation (Figure 4F,
compare lane 2 with lane 4). Thus, Hpo activation in re-
sponse to IR requires new gene transcription, which
could be mediated, at least in part, by Dmp53. Hpo ac-
tivity is induced by Dmp53 expression (Figure 4D), but
Hpo protein itself does not appear to be a target of
Dmp53 because Hpo levels are not detectably upregu-
lated when Dmp53 is expressed in the posterior portion
of the eye imaginal disc (Figure S3C) or in Dmp53-ex-
pressing clones in the wing disc (Figure S3E). Future
studies will be aimed at determining the exact mecha-
nism through which Dmp53 promotes Hpo activation.
In this study, we demonstrate by genetic and bio-
chemical approaches not only that the Hpo pathway is
required for the full apoptotic response induced by g-
ray irradiation but also that DNA damage triggers Hpo ki-
nase activity in a Dmp53-dependent manner both in vivo
and in vitro. We also show that the apoptosis induced by
Dmp53 overexpression is strongly affected in hpo, wts,
and sav mutant clones and that Dmp53 does not modu-
late Hpo levels. This study constitutes the first descrip-
tion of an upstream activating signal of the Hpo complex
in vivo and during organism development.
We note that the blockage of Dmp53-induced apopto-
sis is not complete in hpo clones; this incomplete block-
age likely reflects the role of other pro-apoptotic pro-
teins, such as Reaper, Hid, and Sickle, in this process.
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1455Figure 2. hpo, wts, and sav Mutant Clones
Show Reduced IR-Induced Apoptosis
(A–C) 40 Gy of g rays induces apoptosis after
4 hr, shown by anti-active caspase 3 staining
in wing imaginal disks (B) compared to con-
trol untreated discs (A). Homozygous
p535A-1-4 mutant discs have little detectable
g-ray-induced apoptosis (C). See Experimen-
tal Procedures for genotypes.
(D–F) hpo, wts, and sav mutant clones have
reduced g-ray-induced apoptosis in wing
imaginal disks compared to control tissue.
hpo42-47, wtsX1, and sav3 mutant clones are
labeled by the absence of GFP (green). Apo-
ptosis is visualized in red by anti-cleaved cas-
pase 3 staining. The GFP signal (D0–F0) was
used to separate control (D0 0–F0 0) and mutant
(D0 0 0–F0 0 0) anti-caspase 3 signals. This ap-
proach was used to determine the apoptotic
index (see Experimental Procedures) for the
various mutants (G). Mutant tissues show
a better resistance to g-ray induced apopto-
sis. Statistical significance of the difference
between wild-type and mutant tissue was as-
sessed by a Mann-Whitney non-parametric
test; in all cases, p < 0.01 (**) for the null hy-
pothesis. Number of large clones scored for
individual genotypes: wts n = 28, hpo and
sav n = 34. See Figure S4 and Experimental
Procedures for genotypes.Thus, we propose that, after exposure to ionizing radia-
tions, the dATM, dChk2, Dmp53 signaling pathway [23]
is activated and induces apoptosis by targeting expres-
sion of pro-apoptotic effectors such as Reaper, as well
as by activating the Hpo pathway [24, 25]. This cell-
death response to irradiation requires the caspase
DRONC and leads to upregulation of JNK activity in
a p53-dependent manner [27–30]. Because Hpo has
been shown to induce JNK activation when overex-
pressed in vivo [8], it will be interesting to determine
whether Hpo is necessary for IR-induced JNK activa-
tion.
Several reports have suggested that the mammalian
homologs of members of the Hpo pathway might be-
have as tumor suppressors in humans [2, 7–9]. Inaddition, mice lacking the Wts homolog mLats1 are
more sensitive to tumor-inducing agents [31]. Our data
suggest that one effect of mutations in Hpo-pathway
members may be to protect these cells from DNA-dam-
age-induced apoptosis and thus promote tumor pro-
gression and the accumulation of additional mutations.
Further work on the Hpo pathway should further our un-
derstanding of the DNA-damage response and its role
in the transformation process.
Experimental Procedures
For Drosophila genotypes and further experimental details, see the
Supplementary Experimental Procedures.
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Overexpression Is Reduced in hpo, wts, and
sav Mutant Clones
In all panels, mutant clones are marked by the
absence of GFP (A–E and A0 0–E0 0). Apoptosis
is observed by cleaved caspase 3 staining
in red (A0–E0 and A0 0–D0 0). GMR (Glass multi-
mer reporter)-driven Dmp53 overexpression
in the posterior portion of the imaginal eye
discs induces apoptosis (B–B0 0); compare
with the control (A–A0 0). This is reduced in
hpo42–47 (C–C0 0), wtsX1 (D–D0 0), and sav3 (E–
E0 0) clones. Arrows show that apoptotic cells
are mainly wild-type cells (GFP positive).
Posterior is to the right. See Experimental
Procedures for genotypes.Kc and S2 Cell Assays
In depletion experiments, Drosophila embryonic Kc cells were
treated with Dmp53, DIAP1, Hpo, or eGFP dsRNAs for four days.
dsRNAs were synthetised with T7 Ribomax large-scale RNA pro-
duction systems (Promega) and purified with the MEGAclear system
(Ambion). We treated Kc cells with 1 mM staurosporine (Sigma) for
3 hr to induce Hpo phosphorylation. To inhibit transcription, we
treated Kc cells with 1 mg/ml Actinomycin D (Sigma) for 3 hr.
Western Blotting, Immunoprecipitation, and Hpo Antibody
Generation
For Western blotting, we irradiated tissues or cells with g-rays to in-
duce DNA damage. Tissues were collected 4 hr later, then lysed. Af-
ter material was cleared, samples containing 50 mg of protein were
resolved by SDS-PAGE. Proteins were transferred to PVDF mem-
branes and visualized by immunoblotting. Chemoluminescence
was observed via an ECL-plus-Western-blotting detection system
(Amersham Biosciences). For all Western-blot experiments, the
same membrane was probed first with anti-phospho-Hpo, followed
by Hpo, anti-tags, and anti-tubulin antibodies after stripping.
Phosphatase treatments have been done with Lambda Protein
Phosphatase (New England Biolabs). Proteins (125 mg) were treated
with 500 units of enzyme for 30 min in a 50 ml reaction at 30C. Immu-
noprecipitations were done on 250 mg of protein in lysis buffer for
2 hr at 4C. IP Kinase assays were performed as previously
described [7]. Where indicated, 1 mg of Xenopus laevis Histone
H2B was added to the reaction as a substrate.
The anti-Hpo rabbit antibody was generated and affinity purified
by Eurogentec SA against a peptide corresponding to amino acids
191–203.Genetics and Immunocytochemistry
Mosaic tissues were obtained via the FLP/FRT system. L3 larvae
were irradiated with 40 Gy of g-ray. Four hours after this treatment,
tissues were dissected in 13 PBS, fixed in 4% formaldehyde in PBS
for 20 min at room temperature, and extensively washed in PBS con-
taining 0.1% Triton X-100 (PBT). Tissues were then blocked for 2 hr
in PBT containing 10% goat serum. Primary antibodies were incu-
bated overnight at 4C. Secondary antibodies were incubated for
2 hr at room temperature at 1/500. After washes, tissues were
mounted in Vectashield. Fluorescence images were acquired with
a Zeiss LSM510 Meta confocal microscope.
Supplemental Data
Supplemental Experimental Procedures and figures are available
with this article online at http://www.current-biology.com/cgi/
content/full/16/14/1453/DC1/.
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1457Figure 4. Hpo Activity Is Induced by g Ray Irradiation both In Vivo
and In Vitro in a Dmp53-Dependent Manner
(A) Western blot of Kc cell lysates after g ray treatment with or with-
out Dmp53 depletion by RNAi. Hpo phosphorylation (top row) is in-
duced after 2 hr in RNAi-untreated cells. Dmp53 depletion reduces
Hpo activation. Hpo levels (middle row) remain constant in com-
parison to control levels (anti-tubulin, bottom row). Dmp53 depletion
by RNAi treatment is not complete, as measured by RT-PCR
(Figure S2A). Times after irradiation are shown in hours.
(B) Myc-tagged Hpo was immunoprecipitated from Kc cells treated
as shown. IP kinase assays were performed in the presence of 32P g-
ATP on nine-tenths of the IPs (top lane), whereas one-tenth were
used to check levels of Hpo-Myc (bottom lane). Hpo kinase activity
is strongly induced by IR treatment (compare lanes 1 and 2).
(C) Western blot of g-ray (40 Gy)-treated Dmp53 mutant or wild-type
ovaries 4 hr after irradiation. Hpo phosphorylation is severely re-
duced in Dmp53 mutant animals (top row). Hpo levels (middle row)
and tubulin levels (bottom row) are shown.
(D) Western blot of S2 cell lysates after transfection of Dmp53 or in-
duction of reaper expression. Hpo phosphorylation (top row) is in-
duced by Dmp53 expression (fourth lane) but not by rpr expression
(sixth lane). Induction by CuSO4 has no effect on Hpo activity (third
lane). Hpo levels (second row), HA levels (third row), and tubulin
levels (bottom row) are shown. P-Hpo was also induced by IR alone
in S2 cells (not shown).
(E) Western blot of Kc cells treated with dsRNAs to deplete DIAP1.
Hpo phosphorylation is induced by sts treatment (compare top
row in lanes 1 and 2). DIAP1 depletion fails to induce Hpo phosphor-
ylation (top row, lanes 3). As expected, DIAP1 depletion potently in-
duces cell death (see Figures S2C–S2E). Hpo levels (middle row) and
tubulin levels (bottom row) are shown.
(F) Western blots of g-ray-treated or control Kc cells in the presence
or absence of 1 mg/ml Actinomycin D. g-ray-induced Hpo phosphor-
ylation is severely reduced in the presence of Act D (compare lanes 2
and 4). Hpo levels (middle row) and tubulin levels (bottom row) are
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